Project Grant HT94252410901
Award Date
9/30/24
Completion Date
9/29/27
Dollars Obligated
$1.5M
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Switzerland
Similar Awards
This $490,602 Project Grant awarded by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) federal grant program supports the development of a clinical-grade spinal cord neuroprosthesis to alleviate locomotor deficits in people with Parkinson's disease. The award, effective September 1, 2025 through August 31, 2028, was granted to the Ecole Polytechnique Federale De Lausanne (EPFL), a prominent Swiss research university. Through this project, EPFL will...
This $1,184,252 Project Grant awarded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) will fund the development of a clinical-grade spinal cord neuroprosthesis to alleviate locomotor deficits in people with Parkinson's disease. The grant was awarded to the Centre Hospitalier Universitaire Vaudois (Chuv), a non-profit hospital and research institution in Lausanne, Switzerland, for the project period from September 1, 2025 to August 31,...
This Project Grant award of $568,114.00 from the Defense Health Agency was made to Ecole Polytechnique Fédérale De Lausanne (EPFL), a university in Lausanne, Switzerland, to conduct research and development related to baroprosthesis to reduce secondary damage of traumatic spinal cord injury. The award was made under the Military Medical Research and Development program (CFDA 12.420), which supports biomedical research to transform healthcare for Service Members and the public. The research...
This $1,199,967 Project Grant awarded on September 1, 2023 by the Defense Health Agency supports research under the Military Medical Research and Development (CFDA 12.420) program. The primary award recipient, the University of Vermont & State Agricultural College, will investigate "Cognitive Functions Impairment as a Novel Paradigm for Delineating Cognitive Dysfunction in Parkinson's Disease". Two sub-awards were made to Case Western Reserve University and the Portland VA Research...
This federal Project Grant award from the Defense Health Agency (CFDA 12.420 - Military Medical Research and Development) provides $499,023 to the Centre Hospitalier Universitaire Vaudois (Chuv) in Lausanne, Switzerland to support research examining the mechanisms by which spinal cord stimulation can improve motor deficits in advanced Parkinson's disease. The research project will run from September 30, 2024 to September 29, 2026. In addition, Chuv has received several other significant...
The federal Project Grant award of $2,000,000.00 from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) will support research conducted by the University of Nebraska Medical Center (UNMC) to investigate the interrelationship between the PINK1-PRKN pathway disruption and tauopathy in the pathophysiology of cognitive impairment in Parkinson's disease. The research project aims to advance the understanding of these complex neurological mechanisms, with...
This federal Project Grant award of $1,021,409.00 from the Department of the Army Medical Command under the Military Medical Research and Development (CFDA 12.420) program will support research at the University of Illinois to investigate the underlying neurobiology of non-motor symptoms in Parkinson's disease. The research aims to elucidate the role of serotonin system plasticity in the development of these disabling non-motor complications, which can include cognitive, psychiatric, and...
This Project Grant award of $1,022,173.00 from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) will support research by Virginia Polytechnic Institute & State University (Virginia Tech) on the role of traumatic brain injury in the progression of Parkinson's disease. The award has a performance period from April 15, 2025 to April 14, 2028. This research aims to advance understanding of the relationship between traumatic brain injury and the...
The federal Project Grant award, identified as HT94252510242, was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The purpose of the grant is to elucidate the neural basis of hallucinations in Parkinson's disease. The total award amount is $200,000.00, with a performance period from July 1, 2025 to June 30, 2027. The grant was awarded to Northwestern University, a prominent private research university, to conduct this advanced...
The Department of the Army's Military Medical Research and Development program (CFDA 12.420) has awarded a $325,142 Project Grant to Onward Medical Inc. in Boston, MA. The grant, which runs from September 1, 2025 to August 31, 2028, will fund the development of a "clinical-grade spinal cord neuroprosthesis to alleviate locomotor deficits in people with Parkinson's disease." This research aims to transform healthcare for military service members and the broader public by advancing...